APNA 23rd Annual Clinical Psychopharmacology Institute
Psychopharmacology Updates Planned for Nurses, by Nurses for More Than 20 Years
Registration Opens in January
June 5-8, 2025
Rockville, Maryland or virtual
Earn up to 20+ ANCC NCPD Contact Hours in Pharmacology
“Other pharma-oriented conferences I have attended focused on biomedical processes and products, while CPI focuses on the experience of human problems and the science behind ways to help. APNA CPI elevates my practice to serve my patients better.” – Anthony Peckham, PMHNP-BC
Dr. Nora Volkow to Keynote 2025 Conference!
Nora D. Volkow, M.D., is Director of the National Institute on Drug Abuse (NIDA), the world’s largest funder of scientific research on the health aspects of drug use and addiction.
Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a brain disorder. As a research psychiatrist, Dr. Volkow pioneered the use of brain imaging to investigate how substance use affects brain functions. In particular, her studies have documented how changes in the dopamine system affect the functions of brain regions involved with reward and self-control in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging.
Learn more & see the exciting speakers booked for this year
Master your psychopharmacologic nursing practice across the lifespan.
The APNA Clinical Psychopharmacology Institute (CPI) delivers psychopharmacology updates to professionals looking to provide the best possible care to their patients. CPI prioritizes the integration of psychopharmacology and neuroscience into clinical practice. It offers the scientific base for treatment decisions and addresses the context of care within the nurse/consumer/family relationship.
Join other providers like you.
The APNA Clinical Psychopharmacology Institute is appropriate for RN-PMH and advanced practice psychiatric nurses (PMH-NP & PMH-CNS) – especially those who administer and/or prescribe medications. Because CPI is planned for nurses, by nurses, the program provides a depth and breadth of scientific information tailored to the challenges inherent in psychiatric-mental health nursing practice. All other health care providers interested in psychopharmacology are welcome for advanced study, especially fellow nurses, primary care physicians, psychiatrists, psychologists, and pharmacists.
The content of this CNE activity pertains to pharmacology. Because states’ requirements may vary, contact your Board of Nursing for more information.
The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
